Infinity Pharma (INFI) Posts Q3 Loss of 36c, Beats Eatimates by 8c
More News related to INFI
- Infinity Announces 2009 Financial Results Conference Call
- Infinity Pharma (INFI) Provides FY10 Business and R&D Goals
- Infinity Announces Key 2010 Objectives
- Infinity Announces Updated Presentation Time at the J.P. Morgan Healthcare Conference
- Infinity Announces Presentations at January Conferences
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reports Q3 loss of $0.36, 8 cents better than the analyst estimate of ($0.44). Revenue for the quarter was $13.8 million, which compares to the estimate of $12.41 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
